Sort   by:  
 Page size 
UnknownNew Agents, Emerging Late Effects, and the Development of Precision Survivorship.
Not available
S-EPMC6053298 | biostudies-literature
UnknownManagement of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
Not available
S-EPMC6481621 | biostudies-literature
UnknownProspective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.
Not available
S-EPMC8462523 | biostudies-literature
UnknownImpact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.
Not available
S-EPMC3731920 | biostudies-literature
UnknownLack of association between 25(OH)D levels and incident type 2 diabetes in older women.
Not available
S-EPMC3041195 | biostudies-literature
UnknownMyeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Not available
S-EPMC5455603 | biostudies-literature
UnknownVariants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.
Not available
S-EPMC3240722 | biostudies-literature
UnknownPrecision Population Medicine in Primary Care: The Sanford Chip Experience.
Not available
S-EPMC7994529 | biostudies-literature
UnknownExome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
Not available
S-EPMC4319990 | biostudies-literature
Sort   by:  
 Page size